Impact of cardiovascular illness on hospitalization costs in patients with rheumatoid arthritis

Ricardo Pineda-Tamayo, Giovanna Arcila, Patricia Restrepo, Juan Manuel Anaya

Resultado de la investigación: Contribución a RevistaArtículo

6 Citas (Scopus)

Resumen

The causes of admission and the distribution of direct medical costs were examined to establish the clinical predictors of high hospitalization costs in patients with rheumatoid arthritis. This retrospective study included all rheumatoid arthritis patients who were hospitalized in the Clínica Universitaria Bolivariana in Medellín, Colombia, between January 1999 and June 2003. Data were obtained from the medical records and from the hospital statistical section using a cost-analysis spreadsheet. A total of 41 patients were hospitalized 62 times (0.34 hospitalization per patient per year). Disease activity was the most important cause of admission (60%), followed by surgery (18%), and infection (10%). In 30 (48%) hospitalizations, at least one comorbidity was recorded, with cardiovascular disease being the most frequent (32%). The mean length of stay per patient was 5+/-6 days. The mean total cost was 1,277 US dollars, and the mean cost per day of hospitalization was 235 US dollars. Medications represented 54% of the total cost, whereas that representing medical care was only 3%. Variance analysis disclosed cardiovascular disease as the most important determinant of high costs (p
Idioma originalEnglish (US)
Páginas (desde-hasta)366-374
Número de páginas9
PublicaciónBiomédica : revista del Instituto Nacional de Salud
EstadoPublished - ene 1 2004

Huella dactilar

Rheumatoid Arthritis
Hospitalization
Costs and Cost Analysis
Cardiovascular Diseases
Colombia
Medical Records
Comorbidity
Length of Stay
Analysis of Variance
Retrospective Studies
Infection

Citar esto

@article{b2e90e6f4e9842bc8d0b0ab5034ac024,
title = "Impact of cardiovascular illness on hospitalization costs in patients with rheumatoid arthritis",
abstract = "The causes of admission and the distribution of direct medical costs were examined to establish the clinical predictors of high hospitalization costs in patients with rheumatoid arthritis. This retrospective study included all rheumatoid arthritis patients who were hospitalized in the Cl{\'i}nica Universitaria Bolivariana in Medell{\'i}n, Colombia, between January 1999 and June 2003. Data were obtained from the medical records and from the hospital statistical section using a cost-analysis spreadsheet. A total of 41 patients were hospitalized 62 times (0.34 hospitalization per patient per year). Disease activity was the most important cause of admission (60{\%}), followed by surgery (18{\%}), and infection (10{\%}). In 30 (48{\%}) hospitalizations, at least one comorbidity was recorded, with cardiovascular disease being the most frequent (32{\%}). The mean length of stay per patient was 5+/-6 days. The mean total cost was 1,277 US dollars, and the mean cost per day of hospitalization was 235 US dollars. Medications represented 54{\%} of the total cost, whereas that representing medical care was only 3{\%}. Variance analysis disclosed cardiovascular disease as the most important determinant of high costs (p",
author = "Ricardo Pineda-Tamayo and Giovanna Arcila and Patricia Restrepo and Anaya, {Juan Manuel}",
year = "2004",
month = "1",
day = "1",
language = "English (US)",
pages = "366--374",
journal = "Biomedica",
issn = "0120-4157",
publisher = "Instituto Nacional de Salud",

}

Impact of cardiovascular illness on hospitalization costs in patients with rheumatoid arthritis. / Pineda-Tamayo, Ricardo; Arcila, Giovanna; Restrepo, Patricia; Anaya, Juan Manuel.

En: Biomédica : revista del Instituto Nacional de Salud, 01.01.2004, p. 366-374.

Resultado de la investigación: Contribución a RevistaArtículo

TY - JOUR

T1 - Impact of cardiovascular illness on hospitalization costs in patients with rheumatoid arthritis

AU - Pineda-Tamayo, Ricardo

AU - Arcila, Giovanna

AU - Restrepo, Patricia

AU - Anaya, Juan Manuel

PY - 2004/1/1

Y1 - 2004/1/1

N2 - The causes of admission and the distribution of direct medical costs were examined to establish the clinical predictors of high hospitalization costs in patients with rheumatoid arthritis. This retrospective study included all rheumatoid arthritis patients who were hospitalized in the Clínica Universitaria Bolivariana in Medellín, Colombia, between January 1999 and June 2003. Data were obtained from the medical records and from the hospital statistical section using a cost-analysis spreadsheet. A total of 41 patients were hospitalized 62 times (0.34 hospitalization per patient per year). Disease activity was the most important cause of admission (60%), followed by surgery (18%), and infection (10%). In 30 (48%) hospitalizations, at least one comorbidity was recorded, with cardiovascular disease being the most frequent (32%). The mean length of stay per patient was 5+/-6 days. The mean total cost was 1,277 US dollars, and the mean cost per day of hospitalization was 235 US dollars. Medications represented 54% of the total cost, whereas that representing medical care was only 3%. Variance analysis disclosed cardiovascular disease as the most important determinant of high costs (p

AB - The causes of admission and the distribution of direct medical costs were examined to establish the clinical predictors of high hospitalization costs in patients with rheumatoid arthritis. This retrospective study included all rheumatoid arthritis patients who were hospitalized in the Clínica Universitaria Bolivariana in Medellín, Colombia, between January 1999 and June 2003. Data were obtained from the medical records and from the hospital statistical section using a cost-analysis spreadsheet. A total of 41 patients were hospitalized 62 times (0.34 hospitalization per patient per year). Disease activity was the most important cause of admission (60%), followed by surgery (18%), and infection (10%). In 30 (48%) hospitalizations, at least one comorbidity was recorded, with cardiovascular disease being the most frequent (32%). The mean length of stay per patient was 5+/-6 days. The mean total cost was 1,277 US dollars, and the mean cost per day of hospitalization was 235 US dollars. Medications represented 54% of the total cost, whereas that representing medical care was only 3%. Variance analysis disclosed cardiovascular disease as the most important determinant of high costs (p

M3 - Article

SP - 366

EP - 374

JO - Biomedica

JF - Biomedica

SN - 0120-4157

ER -